2Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med, 2003,25:144-153.
3Wood DA, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease : a paired, cluster-randomised controlled trial. Lancet, 2008,371 : 1999-2012.
4Smith SC, Alien J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation, 2006, 113:2363-2372.
5Luttik ML, Jaarsma T, Sanderman R, et al. The advisory brought to practice: routine screening on depression (and anxiety ) in coronary heart disease ; consequences and implications [J].Eur J Cardiovasc Nurs, 2011, 10 (4): 228-233.
6Kilonzo B, O'Connell R. Secondary prevention and learning needs post p[J]. JClinNurs, 2011, 20 (7 -8): 1160 -1167.
7北京市卫生局基层处.北京市社区慢性病管理手册[S].2010,10:19-30.
8Wijeysundera HC, Tomlinson G, Norris CM, et al. Predicting EQ- 5D utility scores from the Seattle Angina Questionnaire in coronary rtery disease: mapping algorithm using a Bayesian framework [J], Med Decis Making, 2011, 31 (3) : 481 - 493.
9Gulliksson M, Burell G, Vessby B, et al. Randomized con- trolled trial of cognitive behavioral therapy vs standard treat- ment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Pri- mary Health Care project (SUPRIM) [J]. Arch Intern Med, 2011, 171 (2): 134-140.
10Yoan Lamarche,Demetrios Sirounis,Rakesh C. Arora.??A Survey of Standardized Management Protocols After Coronary Artery Bypass Grafting Surgery in Canadian Intensive Care Units(J)Canadian Journal of Cardiology . 2011 (6)
